|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBSCO_ocn979762083 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
151029s2015 gw ob 001 0 eng d |
040 |
|
|
|a DEGRU
|b eng
|e rda
|e pn
|c DEGRU
|d GBVCP
|d DEBBG
|d OCLCQ
|d UIU
|d N$T
|d AGLDB
|d IGB
|d CN8ML
|d SNK
|d INTCL
|d MHW
|d BTN
|d AUW
|d DEGRU
|d OCLCF
|d OCLCQ
|d VTS
|d OCLCQ
|d D6H
|d G3B
|d S8I
|d S8J
|d S9I
|d STF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 933565072
|a 992902302
|
020 |
|
|
|a 9783110853858
|q (electronic bk.)
|
020 |
|
|
|a 311085385X
|q (electronic bk.)
|
024 |
7 |
|
|a 10.1515/9783110853858
|2 doi
|
029 |
1 |
|
|a DEBBG
|b BV043493920
|
029 |
1 |
|
|a DEBSZ
|b 453867898
|
029 |
1 |
|
|a GBVCP
|b 840821727
|
035 |
|
|
|a (OCoLC)979762083
|z (OCoLC)933565072
|z (OCoLC)992902302
|
050 |
|
4 |
|a RC280.P5
|
072 |
|
7 |
|a MED000000
|2 bisacsh
|
072 |
|
7 |
|a MED027000
|2 bisacsh
|
072 |
|
7 |
|a MED038000
|2 bisacsh
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
072 |
|
7 |
|a MED085000
|2 bisacsh
|
072 |
|
7 |
|a HEA
|x 012000
|2 bisacsh
|
072 |
|
7 |
|a HEA
|x 020000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 004000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 101000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 109000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 029000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 040000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 092000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/247
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Prolactinomas :
|b an interdisciplinary approach : Proceedings of the International Symposium on Prolactinomas Graz (Austria), April 29 - May 2, 1984 /
|c edited by L.M. Auer, G. Leb, G. Tscherne, W. Urdl, G.F. Walter.
|
264 |
|
1 |
|a Berlin ;
|a Boston :
|b De Gruyter,
|c [2015]
|
264 |
|
4 |
|c ©1985
|
300 |
|
|
|a 1 online resource (439 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
505 |
0 |
0 |
|t Frontmatter --
|t Preface --
|t Contents --
|t I. Morphology --
|t Structure and ultrastructure of prolactinomas --
|t Prolactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones --
|t Immunocytochemical, chemical and nuclear-DNA studies of pituitary tumours --
|t Hyperplasia of prolactin pituitary cells with or with out microadenoma --
|t Hormone-secretion in cell culture of microprolacti nomas, periadenomatous tissue and capsules --
|t Immunocytochemical, ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas --
|t Immunohìstochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo --
|t New immunocytochemical observations in prolactinomas --
|t Problematic divergencies between clinical and immunocytochemical findings in prolactinomas --
|t Necrosis of prolactinoma cells after bromocriptine treatment --
|t Spontaneous pituitary lesions and plasma prolactin levels in rats --
|t II. Radiology --
|t CT-findings in pituitary adenomas --
|t Comparative study of normal subjects and cases with microadenoma on high-resolution computed tomography --
|t III. Endocrinological and clinical aspects --
|t Actions of dopamine receptor agonists at the pituitary level --
|t Dopamine and prolactinomas --
|t Rhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome --
|t Prolactin responses to thyrotropin-releasing hormone, metoclopramide and insulin-induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients --
|t Evidence for functional impairment of growth hormone secretion in prolactinoma --
|t TSH response to dopamine receptor blockade in women with PRL-secreting microadenoma: Long effect of surgical removal --
|t Prolactin and TSH responses to TRH and domperidone in delayed puberty --
|t Anterior pituitary function in patients with prolactinomas --
|t Pituitary adenomas with hyperprolactinaemia in males --
|t Prolactinoma in multiple endocrine neoplasia type I --
|t Recurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalized microprolactinomas --
|t Impairment of pituitary hormone secretion in patients with prolactinoma --
|t IV. Surgical treatment --
|t The recurrence of pituitary adenoma -- a management challenge --
|t Transsphenoidal operations for prolactinomas --
|t Prolactinomas: surgical results in 96 cases --
|t Effect of transsphenoidal surgery on pituitary function --
|t Transsphenoidal microsurgical treatment of 77 prolactinomas --
|t Review of 56 prolactin-secreting pituitary adenomas --
|t The effect of transsphenoidal selective microadenomectomy on patients with prolactinomas --
|t Surgical results and long-term follow-up in female and male prolactinomas --
|t Otoliquorrhoea in large prolactinomas. Pathomechanism and surgical management --
|t Invasive prolactinomas in adolescents --
|t Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas --
|t Long-term follow-up of prolactinomas. Clinical and morphologic correlation --
|t Clinicopathologîcal and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas --
|t V. Pharmacotherapy --
|t New aspects of medical treatment of prolactinomas --
|t Conservative management of prolactinoma --
|t Effect of bromocriptine therapy on large prolactinomas --
|t Macroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumour calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan --
|t Evidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma --
|t The influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly --
|t Persisting partial suppression of growth hormone excess in acromegaly after long term treatment with bromocriptine --
|t Medical and surgical treatment of micro and macroprolactinomas: seven years follow-up of 65 cases --
|t VI. Aspects of gynecology and obstetrics --
|t Management of prolactinomas in pregnancy --
|t Long-term follow-up of hyperprolactinaemia in women --
|t Prophylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies --
|t Natural regression after pregnancy of a CT visualized microprolactinoma --
|t Prolactin levels and ovarian function after surgical treatment of prolactinomas --
|t Pregnancies after treatment of prolactinomas: course and complications --
|t Psychosomatic findings in patients with elevated prolactin --
|t List of contributors --
|t Authors' index --
|t Subject index.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Prolactinoma
|v Congresses.
|
650 |
|
6 |
|a Prolactinome
|v Congrès.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Holism.
|2 bisacsh
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Reference.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Alternative Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Atlases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Essays.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Family & General Practice.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Holistic Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Osteopathy.
|2 bisacsh
|
650 |
|
7 |
|a Prolactinoma
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
700 |
1 |
|
|a Auer, Ludwig M.
|
700 |
1 |
|
|a Leb, Georg.
|
700 |
1 |
|
|a Tscherne, Gerhard.
|
700 |
1 |
|
|a Urdl, Wolfgang.
|
700 |
1 |
|
|a Walter, Gerhard F.
|
776 |
0 |
8 |
|i Print version:
|z 9783110101539
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1458768
|z Texto completo
|
938 |
|
|
|a De Gruyter
|b DEGR
|n 9783110853858
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1458768
|
994 |
|
|
|a 92
|b IZTAP
|